A type of drug used to prevent migraine may be associated with a reduced risk of glaucoma, according to a study published in Neurology. The study compared 36,822 people who took calcitonin gene-related peptide (CGRP) inhibitor drugs to prevent migraine to the same number of people who took other types of migraine prevention drugs. However, the results do not prove that CGRP inhibitor drugs directly cause the reduced risk of glaucoma; they only show an association.
This article was originally published on MedicalXpress.com
